ALS

Brad Smith becomes first non-verbal ALS patient to narrate video using Neuralink brain chip

Smith's synthetic voice was created by analyzing old recordings made before his illness, allowing him to regain a voice for his thoughts and communicate in a voice similar to his own.

 Brad Smith becomes first non-verbal ALS patient to narrate video using Neuralink brain chip.
 A message on the video board above the court at Hapoel Jerusalem’s Pais Arena encourages fans to support IsrALS and the 12th annual ‘Friends Race for ALS’ on May 22.

Hapoel Jerusalem partners with IsrALS

 PrimeC is a novel therapy with a multi-targeted approach to treat ALS.

NeuroSense’s ALS drug PrimeC shows success in phase 2b, eyes final trial

 A PARTICIPANT in the experiment of the speech neuroprosthesis (speech brain-computer interface) is completely silent, with his mouth closed, imagining saying a syllable. The laptop ‘says’ the syllable for him

Tel Aviv researchers enable artificial speech for paralyzed patients using thought power


Larry Nussbaum, 77, was a fierce advocate for Israel and the Jews – and an exceptional doctor

Dr. Nussbaum was an accomplished Doctor, as well as a loving husband and father.

Jpost_Image

An increase in macrophage migration inhibitory factor (MIF) may treat ALS, study finds

ALS, the most common motor neuron disease in adults, is a fatal neurodegenerative disorder characterized by selective degeneration of both upper and lower motor neurons.

Petri dishes are pictured in an unknown location in a Cancer Research UK laboratory on an unknown date.

Breakthrough research on fruit flies may pave way for ALS cure

The work on fruit flies in the lab shows how protein interactions can preserve or prevent the nerve cell death that is a hallmark of ALS.

Petri dishes are pictured in an unknown location in a Cancer Research UK laboratory on an unknown date.

Israeli firm uses AI to help fully paralyzed woman speak again

The groundbreaking Israeli development allows patients to regain their voice with the help of AI

 Debi Admoni

Ady Barkan, healthcare activist who fought Lou Gehrig’s disease, dies at 39

In 2017, as a new father given just years to live, he literally threw his body into action, protesting Republican initiatives at the U.S. Capitol, crisscrossing the country and raising millions.

Technicians help develop a stem cell treatment for nerve-degenerative disease ALS in the laboratory.

Tiny sensors allows this ALS patient to communicate

At 62 words per minute, with a vocabulary of 125,000, brain sensor implants helped interpret a woman's intended speech and printed it on screen.

 Frank Willett operates software that translates Pat Bennett's attempts at speech - recorded by sensors in her brain - into words on a screen.

Israeli chain launches campaign for Global ALS Awareness Day

In honor of the Global ALS Awareness Day, Israeli chain Noi Sheda and IsrA.L.S. Association is partnering up for a new campaign.

Prof. Boaz Lerner of Ben-Gurion University uses a new platform for predicting ALS disease progression

Elite soccer players 1.5 times more likely to develop Alzheimer's -study

A new study aimed to determine the risk of neurodegenerative disease among male players in the top Swedish soccer division Allsvenskan compared to the general population.

Djurgarden's Jonathan Ring in action with Sirius' Karl Larson - Allsvenskan - IK Sirius v Djurgardens IF - Uppsala, Sweden, June 14, 2020

New research uncovers method to prevent DNA breakdown, aging - study

The research focuses on a protein called SIRT6, which seems to have remarkable properties.

 What are the scientific processes behind aging?

Weizmann Institute researchers discover new Lou Gehrig’s disease neural pathway

The incurable neurological condition, which affects about one in 50,000 people, gradually paralyzes patients, halting the ability to speak, eat, move and even breathe.

 Microglia (green) that were “matured” in the lab from stem cells of ALS patients; the cells’ nuclei are in blue. Viewed with confocal microscopy

Is ALS reversible? -TAU study

Researchers from Tel Aviv University identified the biological mechanism causing nerve destruction in the neurodegenerative disease ALS.

 Tel Aviv University Campus